🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Softgel(s) Serving Size
45 Servings
Fat/Fatty Acid Product Type
20% Evidence Coverage

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Fat
2 Gram(s) (3% DV)
Cholesterol
5 mg (1% DV)
Sodium
82 mg (4% DV)
2 Gram(s)
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 2mg UL 3000mg

Other Ingredients

Gelatin Glycerin Water, Purified Mixed Tocopherols Sunflower Oil Enteric Coating

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Take two soft gels daily.

⚠️ Warnings & Precautions

Contains: Fish (Alaskan Walleye Polluck)

Do not use if you are taking physician prescribed blood thinning agents.

🧪 Formulation Notes

SFH Fish Oil is derived from wild-caught Alaskan pollock from the Bering Sea.

Sustainably sourced Our fish oil meets the highest standard of sustainable fishing practices.

This product has been manufactured in a GMP registered facility.

2000mg Fish Oil 1100mg EPA 400mg DHA

May support heart, brain, joint

Additional Information

Learn more at sfh.com

IFOS (International Fish Oil Standards) www.ifosprogram.com

NSF Certified for Sport

GMP Certified GMP Manufactured

Every product is backed by our 100% satisfaction guarantee. Simply return your product within 30 days of purchase. If you have any questions or concerns, please contact customer service at (877) 682-9067 or customerservice@sfh.com

SFH Est. 2010

Product Details

UPC / SKU 811418021446
DSLD Entry Date 2022-01-22
Product Type Fat/Fatty Acid
Form Softgel Capsule
DSLD ID 261961
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →